Intelligent Medicine Acquisition Corp. ( IQMD) Stock. Should you Buy or Sell? $ 10.05
-0.01 (0.00 %)
Intelligent Medicine Acquisition Corp. Analysis
Updated on 10-09-2022
Symbol |
IQMD |
Price |
$10.05 |
Beta |
0.000 |
Volume Avg. |
$45.84 thousand |
Market Cap |
$259.91 M |
52 Week Range |
$9.86 - $10.93 |
Intelligent Medicine Acquisition Corp. opened the day at $10.05 which is 0.00 % on yesterday's close.
Intelligent Medicine Acquisition Corp. has a 52 week high of $10.93 and 52 week low of $9.86, which is a difference of $1.07.
We like to see positive, upward trending shares, preferably with momentum.
Market capitalization is $259.91 M and total net profit is $0 which means the company is trading at inf times profit to market capitalization. Theoretically, if you were to buy Intelligent Medicine Acquisition Corp. for $259.91 M, it would take 15 years to get your money back. Intelligent Medicine Acquisition Corp. are in the Shell Companies space which will have a sweet spot and industry standard for net profit multiples.
Price Chart
1 D | All
Financials
Intelligent Medicine Acquisition Corp. Stock Forecast - Is Intelligent Medicine Acquisition Corp. a Buy or Sell?
DCF Score | | Strong Buy |
ROE Score | | Sell |
ROA Score | | Neutral |
DE Score | | Sell |
PE Score | | Strong Buy |
PB Score | | Strong Sell |
Overall Recommendation | | Neutral |
Growth and Value
PE Ratio |
0.000 |
Dividend Yiel |
0.000 |
Net Profit Margin |
0.000 |
Valuing Intelligent Medicine Acquisition Corp.
Price Book Value Ratio |
-15.840 |
Price To Book Ratio |
-15.840 |
Price To Sales Ratio |
0.000 |
Price Earnings Ratio |
0.000 |
How liquid is Intelligent Medicine Acquisition Corp.
Current Ratio |
0.751 |
Quick Ratio |
0.452 |
Debt
Debt Ratio |
0.064 |
Debt Equity Ratio |
-1.036 |
Long Term Debt To Capitalization |
0.000 |
Total Debt To Capitalization |
0.000 |
Latest news about Intelligent Medicine Acquisition Corp.
About Intelligent Medicine Acquisition Corp.
CEO :
Sector : Financial Services
Industry : Shell Companies
Exchange : NASDAQ Global Market
Description :
Intelligent Medicine Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. It intends to identify business opportunities in the field of life science. The company was incorporated in 2021 and is based in Bethesda, Maryland.